US Patent 10968180 Piperidine derivatives as HDAC1/2 inhibitors
Patent 10968180 was granted and assigned to Regenacy Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10968180 Piperidine derivatives as HDAC1/2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
